Rapid Micro Biosystems (RPID) Q3 Revenue Rose 21.6% to $9.5M
Q3 2026 revenue rose 21.6% to $9.5M from $7.8M a year earlier. Gross margin was 25.2%, compared with 8.9%; the company withdrew its 2026 guidance and delayed its Form 10-Q filing.Material DetailsContext by AI AnalystThese results show improving revenue and gross margin, but Rapid remains loss-makin…